Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Apellis Pharmaceuticals Inc banner

Apellis Pharmaceuticals Inc
NASDAQ:APLS

Watchlist Manager
Apellis Pharmaceuticals Inc Logo
Apellis Pharmaceuticals Inc
NASDAQ:APLS
Watchlist
Price: 23.27 USD 3.15%
Market Cap: $2.9B
Write Note Create Alert Ask AI

Intrinsic Value

The intrinsic value of one APLS stock under the Base Case scenario is hidden USD. Compared to the current market price of 23.27 USD, Apellis Pharmaceuticals Inc is hidden .

Valuation Methods:
DCF Value
Hidden
Relative Value
Hidden
DCF Value
Hidden
Relative Value
Hidden
APLS Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
Apellis Pharmaceuticals Inc

Intrinsic Value History
Dive into the past to invest in the future

APLS looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if APLS is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about APLS?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is APLS valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Apellis Pharmaceuticals Inc.

Explain Valuation
Compare APLS to

Fundamental Analysis

How do you feel about APLS?
Bearish
Neutral
Bullish
Financials
Efficiency

Earnings Waterfall
Apellis Pharmaceuticals Inc

Wall St
Price Targets

APLS Price Targets Summary
Apellis Pharmaceuticals Inc

Wall Street analysts forecast APLS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for APLS is 34.83 USD with a low forecast of 19.19 USD and a high forecast of 57.75 USD.

APLS Lowest Forecast
Wall Street Target
19.19 USD
-18% Downside
APLS Average Forecast
Wall Street Target
34.83 USD
50% Upside
APLS Highest Forecast
Wall Street Target
57.75 USD
148% Upside
Lowest
Price Target
19.19 USD
18% Downside
Average
Price Target
34.83 USD
50% Upside
Highest
Price Target
57.75 USD
148% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Apellis Pharmaceuticals Inc
does not pay dividends
Shareholder Yield
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Ownership

APLS Insider Trading
Buy and sell transactions by insiders

APLS News

See Also

Summary
APLS intrinsic value, competitors valuation, and company profile.
DCF Valuation
APLS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
APLS stock valuation using valuation multiples.
Wall Street Estimates
APLS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
APLS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is the Intrinsic Value of one APLS stock?

The intrinsic value of one APLS stock under the Base Case scenario is hidden USD.

Is APLS stock undervalued or overvalued?

Compared to the current market price of 23.27 USD, Apellis Pharmaceuticals Inc is hidden .

Back to Top
ALPHA SPREAD
Follow us
Join more than 315,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.